Selected research
Market Structure
Global Mesna (Mesnex) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Mesna (Mesnex) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Mesna (Mesnex) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mesna (Mesnex) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mesna (Mesnex) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Mesna (Mesnex) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mesna (Mesnex) include Teva Pharmaceutical, Mylan, Jiangsu Hengrui Medicine, Fresenius Kabi, Baxter, Sagent Pharmaceuticals, Hikma Pharmaceuticals, Gland Pharma Limited and Athenex Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Mesna (Mesnex) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mesna (Mesnex) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mesna (Mesnex) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesna (Mesnex) market size, projected growth trends, production technologies, key applications, and end-use industries.
Mesna (Mesnex) Segment by Company
Teva Pharmaceutical
Mylan
Jiangsu Hengrui Medicine
Fresenius Kabi
Baxter
Sagent Pharmaceuticals
Hikma Pharmaceuticals
Gland Pharma Limited
Athenex Pharmaceuticals
Mesna (Mesnex) Segment by Type
Oral
Injections
Mesna (Mesnex) Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Mesna (Mesnex) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesna (Mesnex) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesna (Mesnex) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesna (Mesnex).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mesna (Mesnex) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesna (Mesnex) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesna (Mesnex) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Mesna (Mesnex) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injections
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Teva Pharmaceutical
- Mylan
- Jiangsu Hengrui Medicine
- Fresenius Kabi
- Baxter
- Sagent Pharmaceuticals
- Hikma Pharmaceuticals
- Gland Pharma Limited
- Athenex Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Mesna (Mesnex) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Mesna (Mesnex) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Mesna (Mesnex) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Mesna (Mesnex) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Mesna (Mesnex) Market Dynamics
- 2.1 Mesna (Mesnex) Industry Trends
- 2.2 Mesna (Mesnex) Industry Drivers
- 2.3 Mesna (Mesnex) Industry Opportunities and Challenges
- 2.4 Mesna (Mesnex) Industry Restraints
3 Mesna (Mesnex) Market by Manufacturers
- 3.1 Global Mesna (Mesnex) Revenue by Manufacturers (2021-2026)
- 3.2 Global Mesna (Mesnex) Sales by Manufacturers (2021-2026)
- 3.3 Global Mesna (Mesnex) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Mesna (Mesnex) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mesna (Mesnex) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Mesna (Mesnex) Manufacturers, Product Type & Application
- 3.7 Global Mesna (Mesnex) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mesna (Mesnex) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mesna (Mesnex) Players Market Share by Revenue in 2025
- 3.8.3 2025 Mesna (Mesnex) Tier 1, Tier 2, and Tier 3
4 Mesna (Mesnex) Market by Type
- 4.1 Mesna (Mesnex) Type Introduction
- 4.1.1 Oral
- 4.1.2 Injections
- 4.2 Global Mesna (Mesnex) Sales by Type
- 4.2.1 Global Mesna (Mesnex) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mesna (Mesnex) Sales by Type (2021-2032)
- 4.2.3 Global Mesna (Mesnex) Sales Market Share by Type (2021-2032)
- 4.3 Global Mesna (Mesnex) Revenue by Type
- 4.3.1 Global Mesna (Mesnex) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Mesna (Mesnex) Revenue by Type (2021-2032)
- 4.3.3 Global Mesna (Mesnex) Revenue Market Share by Type (2021-2032)
5 Mesna (Mesnex) Market by Application
- 5.1 Mesna (Mesnex) Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Mesna (Mesnex) Sales by Application
- 5.2.1 Global Mesna (Mesnex) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mesna (Mesnex) Sales by Application (2021-2032)
- 5.2.3 Global Mesna (Mesnex) Sales Market Share by Application (2021-2032)
- 5.3 Global Mesna (Mesnex) Revenue by Application
- 5.3.1 Global Mesna (Mesnex) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Mesna (Mesnex) Revenue by Application (2021-2032)
- 5.3.3 Global Mesna (Mesnex) Revenue Market Share by Application (2021-2032)
6 Global Mesna (Mesnex) Sales by Region
- 6.1 Global Mesna (Mesnex) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mesna (Mesnex) Sales by Region (2021-2032)
- 6.2.1 Global Mesna (Mesnex) Sales by Region (2021-2026)
- 6.2.2 Global Mesna (Mesnex) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Mesna (Mesnex) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Mesna (Mesnex) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Mesna (Mesnex) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Mesna (Mesnex) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Mesna (Mesnex) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Mesna (Mesnex) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Mesna (Mesnex) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Mesna (Mesnex) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Mesna (Mesnex) Revenue by Region
- 7.1 Global Mesna (Mesnex) Revenue by Region
- 7.1.1 Global Mesna (Mesnex) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Mesna (Mesnex) Revenue by Region (2021-2026)
- 7.1.3 Global Mesna (Mesnex) Revenue by Region (2027-2032)
- 7.1.4 Global Mesna (Mesnex) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Mesna (Mesnex) Revenue (2021-2032)
- 7.2.2 North America Mesna (Mesnex) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Mesna (Mesnex) Revenue (2021-2032)
- 7.3.2 Europe Mesna (Mesnex) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Mesna (Mesnex) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Mesna (Mesnex) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Mesna (Mesnex) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Mesna (Mesnex) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceutical
- 8.1.1 Teva Pharmaceutical Company Information
- 8.1.2 Teva Pharmaceutical Business Overview
- 8.1.3 Teva Pharmaceutical Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceutical Mesna (Mesnex) Product Portfolio
- 8.1.5 Teva Pharmaceutical Recent Developments
- 8.2 Mylan
- 8.2.1 Mylan Company Information
- 8.2.2 Mylan Business Overview
- 8.2.3 Mylan Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mylan Mesna (Mesnex) Product Portfolio
- 8.2.5 Mylan Recent Developments
- 8.3 Jiangsu Hengrui Medicine
- 8.3.1 Jiangsu Hengrui Medicine Company Information
- 8.3.2 Jiangsu Hengrui Medicine Business Overview
- 8.3.3 Jiangsu Hengrui Medicine Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangsu Hengrui Medicine Mesna (Mesnex) Product Portfolio
- 8.3.5 Jiangsu Hengrui Medicine Recent Developments
- 8.4 Fresenius Kabi
- 8.4.1 Fresenius Kabi Company Information
- 8.4.2 Fresenius Kabi Business Overview
- 8.4.3 Fresenius Kabi Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Fresenius Kabi Mesna (Mesnex) Product Portfolio
- 8.4.5 Fresenius Kabi Recent Developments
- 8.5 Baxter
- 8.5.1 Baxter Company Information
- 8.5.2 Baxter Business Overview
- 8.5.3 Baxter Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Baxter Mesna (Mesnex) Product Portfolio
- 8.5.5 Baxter Recent Developments
- 8.6 Sagent Pharmaceuticals
- 8.6.1 Sagent Pharmaceuticals Company Information
- 8.6.2 Sagent Pharmaceuticals Business Overview
- 8.6.3 Sagent Pharmaceuticals Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sagent Pharmaceuticals Mesna (Mesnex) Product Portfolio
- 8.6.5 Sagent Pharmaceuticals Recent Developments
- 8.7 Hikma Pharmaceuticals
- 8.7.1 Hikma Pharmaceuticals Company Information
- 8.7.2 Hikma Pharmaceuticals Business Overview
- 8.7.3 Hikma Pharmaceuticals Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hikma Pharmaceuticals Mesna (Mesnex) Product Portfolio
- 8.7.5 Hikma Pharmaceuticals Recent Developments
- 8.8 Gland Pharma Limited
- 8.8.1 Gland Pharma Limited Company Information
- 8.8.2 Gland Pharma Limited Business Overview
- 8.8.3 Gland Pharma Limited Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Gland Pharma Limited Mesna (Mesnex) Product Portfolio
- 8.8.5 Gland Pharma Limited Recent Developments
- 8.9 Athenex Pharmaceuticals
- 8.9.1 Athenex Pharmaceuticals Company Information
- 8.9.2 Athenex Pharmaceuticals Business Overview
- 8.9.3 Athenex Pharmaceuticals Mesna (Mesnex) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Athenex Pharmaceuticals Mesna (Mesnex) Product Portfolio
- 8.9.5 Athenex Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Mesna (Mesnex) Value Chain Analysis
- 9.1.1 Mesna (Mesnex) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Mesna (Mesnex) Production Mode & Process
- 9.2 Mesna (Mesnex) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Mesna (Mesnex) Distributors
- 9.2.3 Mesna (Mesnex) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst